Thompson Siegel & Walmsley’s United States Antimony UAMY Stock Holding History

Thompson Siegel & Walmsley’s Portfolio UAMY Stock Details UAMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$544K	Buy	+75,000	New	+$678K	0.01%	357

Other funds holding UAMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Thompson Siegel & Walmsley's UAMY Position: Q2 2026 in Review

Thompson Siegel & Walmsley opened a new position in United States Antimony (UAMY) in Q2 2026: 75,000 shares worth $544K. The stake represents 0.01% of the portfolio and ranks #357 among its holdings.

238 funds tracked by Wall St. Rank hold UAMY as of Q2 2026.

Thompson Siegel & Walmsley held 75,000 shares of United States Antimony worth $544K as of Q2 2026.
United States Antimony was a new Thompson Siegel & Walmsley position in Q2 2026.
United States Antimony made up 0.01% of Thompson Siegel & Walmsley's portfolio in Q2 2026, its #357 holding.
238 funds tracked by Wall St. Rank held United States Antimony as of Q2 2026.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2026, filed 11 Aug 2026.